RegenLab France, a cell and tissue engineering firm, receives EU-EIB Innovation Champion title.

RegenLab France, a pioneering biotech firm specializing in cell and tissue engineering medical devices, has been awarded the EU-EIB Innovation Champion title. The European Investment Bank (EIB) recognized the company's dedication to advancing medical science, with a focus on innovation in cell therapies and reshoring in France. The award also celebrates the successful completion of RegenLab's French factory.